Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nuvectis Pharma, Inc. | Chief Science & Business Off | Common Stock | 1.51M | $7.52M | $4.99 | Nov 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVCT | Nuvectis Pharma, Inc. | Nov 19, 2024 | 1 | $9.98K | 4 | Nov 20, 2024 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | May 10, 2024 | 1 | $3.15K | 4 | May 13, 2024 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | Jan 3, 2024 | 1 | $0 | 4 | Jan 5, 2024 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | Mar 27, 2023 | 1 | $5.78K | 4 | Mar 28, 2023 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | Jan 12, 2023 | 1 | $0 | 4 | Jan 13, 2023 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | May 12, 2022 | 2 | $10.3K | 4 | May 16, 2022 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Chief Science & Business Off |
NVCT | Nuvectis Pharma, Inc. | Feb 8, 2022 | 0 | $0 | 3 | Feb 8, 2022 | Chief Science and Business Off |
NVCT | Nuvectis Pharma, Inc. | Feb 4, 2022 | 2 | $15.8K | 4 | Feb 8, 2022 | Chief Science & Business Off |